ArrayExpress Uploaderarrayexpress_sidmouse0Healthyuntreated control0Healthyuntreated control0Healthyuntreated control0STZ diabeticuntreated control0STZ diabeticuntreated control0STZ diabeticuntreated control0Healthysaline0Healthysaline0Healthysaline0Healthysaline0STZ diabeticsaline0STZ diabeticsaline0STZ diabeticsaline75HealthypGG2-CMV75HealthypGG2-CMV75HealthypGG2-CMV75STZ diabeticpGG2-CMV75STZ diabeticpGG2-CMV75STZ diabeticpGG2-CMV75HealthypGG2-CMV-hINS and pGG2-CMV-rGck75HealthypGG2-CMV-hINS and pGG2-CMV-rGck75HealthypGG2-CMV-hINS and pGG2-CMV-rGck75STZ diabeticpGG2-CMV-hINS and pGG2-CMV-rGck75STZ diabeticpGG2-CMV-hINS and pGG2-CMV-rGck75STZ diabeticpGG2-CMV-hINS and pGG2-CMV-rGck886508Many concurrent arrays were run for different projects. All test conditions were tested in all animal models. Animal models were (i)...E-MEXP-2191/profile/8773/arrayexpressuploader325insulinDec.12, 2014FalseE-MEXP-2191_A-AFFY-36transcription-profiling-of-mouse-cd1-wild-types-orTranscription profiling of mouse CD1 wild types or induced diabetic littermates treated with human insulin and rat glucokinaseNov.24, 2014Many concurrent arrays were run for different projects. All test conditions were tested in all animal models. Animal models were (i) healthy CD1 mice (abbreviation CN), or (ii) STZ-induced diabetic CD1 littermates (STZ). Treatment conditions were (i) untreated animals (no prefix), (ii) treatment with 30ul saline and electrotransfer ("e" prefix), (iii) treatment with 75ug noncoding parental plasmid pGG2-CMV ("p" prefix), or (iv) treatment with 37.5ug each (75ug net) of pGG2-CMV-hIns and pGG2-CMV-rGck expressing human insulin and rat glucokinase respectively ("t" prefix). All samples were harvested 7 days after treatment.http://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2191http://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2191/samples/